Vikram Venkatram is a Research Analyst at Georgetown’s Center for Security and Emerging Technology (CSET), where he focuses on emerging issues in biotechnology. His prior work has addressed biosecurity and biohazard response, dual-use neuroscience and technology, and global surveillance and policy, and has been featured by the U.S. Department of Defense, the Atlantic Council, and the Mad Scientist Network of US Army Training and Doctrine Command (TRADOC). Previously, he interned at the Atlantic Council and the U.S. Department of State. Vikram has an M.A. in Security Studies from Georgetown University’s School of Foreign Service, and a B.S.F.S. in Science, Technology, and International Affairs with a minor in Biology, also from Georgetown University.
Related Content
The recent Executive Order on the Safe, Secure, and Trustworthy Development and Use of Artificial Intelligence will have major implications for biotechnology. The EO demonstrates that the White House considers biorisk… Read More
Antimicrobial resistance (AMR) is one of the world’s most pressing global health threats. Basic research is the first step towards identifying solutions. This brief examines the AMR research landscape since 2000, finding that the amount… Read More
Large Language Models in Biology
June 2023Steph Batalis, Caroline Schuerger and Vikram Venkatram explore three notable areas in the life sciences where LLMs are catalyzing meaningful advances: drug discovery, genetics, and precision medicine. Read More
CSET's Dr. Caroline Schuerger, Dr. Steph Batalis, and Vikram Venkatram submitted this comment with recommendations for the National Biotechnology and Biomanufacturing Initiative. Read More
CSET's Steph Batalis and Vikram Venkatram shared their expert analysis in an op-ed published by The Bulletin of the Atomic Scientists. The article explores discusses the complexities and challenges of screening DNA synthesis orders to… Read More
RFI Response: Safety Considerations for Chemical and/or Biological AI Models
December 2024Dr. Steph Batalis and Vikram Venkatram offered the following comment in response to the National Institute of Standards and Technology's request for information on safety considerations for chemical and biological AI models. Read More
180 Days After the Executive Order on Artificial Intelligence: What Comes Next for Biotech?
July 2024Now that the first set of milestones has passed for the Biden administration’s October 2023 executive order on artificial intelligence, where do things stand for biotech? This blog post gives an overview of the most… Read More
Medical artificial intelligence, which depends on large repositories of biological data, can improve public health and contribute to the growing global bioeconomy. Countries that strategically prioritize medical AI could benefit from a competitive advantage and… Read More
Bibliometric Analysis of China’s Non-Therapeutic Brain-Computer Interface Research
March 2024China’s brain-computer interface research has two dimensions. Besides its usual applications in neuropathology, China is extending the benefits of BCI to the general population, aiming at enhanced cognition and a “merger” of natural and artificial… Read More
The recent Executive Order on the Safe, Secure, and Trustworthy Development and Use of Artificial Intelligence will have major implications for biotechnology. The EO demonstrates that the White House considers biorisk… Read More
Antimicrobial resistance (AMR) is one of the world’s most pressing global health threats. Basic research is the first step towards identifying solutions. This brief examines the AMR research landscape since 2000, finding that the amount… Read More
Large Language Models in Biology
June 2023Steph Batalis, Caroline Schuerger and Vikram Venkatram explore three notable areas in the life sciences where LLMs are catalyzing meaningful advances: drug discovery, genetics, and precision medicine. Read More
CSET's Dr. Caroline Schuerger, Dr. Steph Batalis, and Vikram Venkatram submitted this comment with recommendations for the National Biotechnology and Biomanufacturing Initiative. Read More
CSET's Steph Batalis and Vikram Venkatram shared their expert analysis in an op-ed published by The Bulletin of the Atomic Scientists. The article explores discusses the complexities and challenges of screening DNA synthesis orders to… Read More
RFI Response: Safety Considerations for Chemical and/or Biological AI Models
December 2024Dr. Steph Batalis and Vikram Venkatram offered the following comment in response to the National Institute of Standards and Technology's request for information on safety considerations for chemical and biological AI models. Read More
180 Days After the Executive Order on Artificial Intelligence: What Comes Next for Biotech?
July 2024Now that the first set of milestones has passed for the Biden administration’s October 2023 executive order on artificial intelligence, where do things stand for biotech? This blog post gives an overview of the most… Read More
Medical artificial intelligence, which depends on large repositories of biological data, can improve public health and contribute to the growing global bioeconomy. Countries that strategically prioritize medical AI could benefit from a competitive advantage and… Read More
Bibliometric Analysis of China’s Non-Therapeutic Brain-Computer Interface Research
March 2024China’s brain-computer interface research has two dimensions. Besides its usual applications in neuropathology, China is extending the benefits of BCI to the general population, aiming at enhanced cognition and a “merger” of natural and artificial… Read More
The recent Executive Order on the Safe, Secure, and Trustworthy Development and Use of Artificial Intelligence will have major implications for biotechnology. The EO demonstrates that the White House considers biorisk… Read More
Antimicrobial resistance (AMR) is one of the world’s most pressing global health threats. Basic research is the first step towards identifying solutions. This brief examines the AMR research landscape since 2000, finding that the amount… Read More
Large Language Models in Biology
June 2023Steph Batalis, Caroline Schuerger and Vikram Venkatram explore three notable areas in the life sciences where LLMs are catalyzing meaningful advances: drug discovery, genetics, and precision medicine. Read More
CSET's Dr. Caroline Schuerger, Dr. Steph Batalis, and Vikram Venkatram submitted this comment with recommendations for the National Biotechnology and Biomanufacturing Initiative. Read More